Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25
Published September 16, 2026 · Recall initiated: August 5, 2026
Summary
FDA records medical device Class II recall Z-3135-2026, published September 16, 2026 and initiated August 5, 2026. Recalling firm: Nipro Renal Soultions USA, Corporation; Status: Ongoing; Reported quantity: 7,770 cases; Lot: DCA+200-25 : Lots - NDC5E015(Exp.5/20/2027), NDC5E016(Exp.5/21/2027), NDC5E017(Exp.5/22/2027), NDC5E019(Exp.5/29/2027), NDC5E012(Exp.5/19/2027), NDC5B017(Exp.2/24/2027), NDC5C023(Exp.3/24/2027) DCA+203-25: NDC5C026(Exp.3/27/2027), NDC5L026(Exp.11/17/2027). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Hemodialysis concentrates contain high endotoxin levels
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Nipro Renal Soultions USA, Corporation
- Distributor
- Worldwide - US Nationwide distribution in the states of FL, GA, IL, MD, MI, NC, NJ, NV, OH, PA, and the countries of Guatemala and Panama.
- Lot
- DCA+200-25 : Lots - NDC5E015(Exp.5/20/2027), NDC5E016(Exp.5/21/2027), NDC5E017(Exp.5/22/2027), NDC5E019(Exp.5/29/2027), NDC5E012(Exp.5/19/2027), NDC5B017(Exp.2/24/2027), NDC5C023(Exp.3/24/2027) DCA+203-25: NDC5C026(Exp.3/27/2027), NDC5L026(Exp.11/17/2027)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAFluphenazine HCl Elixir, USP, 2.5 mg per 5 mL, Delivers: 5 mL, Oral Elixir, PAI, Alcohol 14% by volume, ForSeptember 23, 2026
- FDAMedicaLyte Liquid Bicarbonate Concentrate REF: BC-100 and BC+201September 16, 2026
- FDACitric Complete Liquid Citric Acid Concentrate REF: LC+200-D,LC+201, LC+225(45X)September 16, 2026
- FDAMedicaLyte Bicarbonate Powder REF: DB+201-2.1(45X) and DB+201-25 (35X, 36.83X, 45X))September 16, 2026
- FDAAMS Convenience Kit: DSAEK Pack - RX, Part Number AMS12394BSeptember 16, 2026
- FDAHeartSine SAM 350P 350P US Device, US English - 2 Min CPR UDI-DI codes: 0506016712067 350P US Device, USSeptember 16, 2026
Questions about this recall
Was Citric Complete Dry Citric Acid Concentrate REF: DCA+200-25 & DCA+203-25 recalled?
Yes. FDA published recall Z-3135-2026 on September 16, 2026. Reported hazard: Hemodialysis concentrates contain high endotoxin levels
What should I do if I have this product?
Voluntary: Firm initiated · Letter